A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank

By sjmartinez • February 16, 2023

Kim DH, Jensen A, Jones K, Raghavan S, Phillips LS, Hung A, Sun YV, Li G, Reaven P, Zhou H, Zhou JJ. A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank. JAMIA Open. 2023 Feb 9;6(1):ooad006. doi: 10.1093/jamiaopen/ooad006. PMID: 36789288; PMCID: PMC9912368.

Tags: diabetes, diabetes complications, disease progression, Electronic health records, General Internal Medicine, phenotyping, Publications, time-to-event

Domestic violence laws and women’s unmet need for family planning: Quasi-experimental evidence from Africa

Bhuwania P, Raub A, Sprague A, Martin A, Bose B, Kidman R, Heymann J. Domestic violence laws and women's unmet need for family planning: Quasi-experimental[...]

The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial

Golub LS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari[...]

Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target Trial Emulation

Watanabe A, Kuno T, Miyamoto Y, Ueyama HA, Gotanda H, Bangalore S, Tsugawa Y. Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target[...]